Maria Mirotsou

Person

Durham, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Direct reprogramming of cells to cardiac myocyte fate
- Patent number 11,534,464
- Issue date Dec 27, 2022
- Duke University
- Victor J. Dzau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Direct reprogramming of cells to cardiac myocyte fate
- Patent number 10,695,378
- Issue date Jun 30, 2020
- Duke University
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of histone methyltransferase for cardiac reprogramming
- Patent number 10,130,637
- Issue date Nov 20, 2018
- Duke University
- Victor J. Dzau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Direct reprogramming of cells to cardiac myocyte fate
- Patent number 9,987,309
- Issue date Jun 5, 2018
- Duke University
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing cell death by administering a paracrine factor d...
- Patent number 9,353,168
- Issue date May 31, 2016
- The Brigham & Women's Hospital, Inc.
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing cell death by administering a nucleic acid encod...
- Patent number 9,279,012
- Issue date Mar 8, 2016
- The Brigham & Women's Hospital, Inc.
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of reducing cell death by administering a paracrine factor o...
- Patent number 8,703,710
- Issue date Apr 22, 2014
- The Brigham & Women's Hospital, Inc.
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DIRECT REPROGRAMMING OF CELLS TO CARDIAC MYOCYTE FATE
- Publication number 20200345786
- Publication date Nov 5, 2020
- DUKE UNIVERSITY
- Victor J. Dzau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING
- Publication number 20190192533
- Publication date Jun 27, 2019
- DUKE UNIVERSITY
- Victor J. Dzau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Direct Reprogramming of Cells to Cardiac Myocyte Fate
- Publication number 20180344776
- Publication date Dec 6, 2018
- DUKE UNIVERSITY
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS
- Publication number 20170128526
- Publication date May 11, 2017
- The Brigham & Women's Hospital, Inc.
- Victor Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibition of Histone Methyltransferase for Cardiac Reprogramming
- Publication number 20150297611
- Publication date Oct 22, 2015
- DUKE UNIVERSITY
- Victor J. Dzau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stem Cell Derived Factors for Treating Pathologic Conditions
- Publication number 20140357703
- Publication date Dec 4, 2014
- Victor J. Dzau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Stem Cell Derived Factors for Treating Pathologic Conditions
- Publication number 20140296152
- Publication date Oct 2, 2014
- DUKE UNIVERSITY
- Victor J. Dzau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Direct Reprogramming of Cells to Cardiac Myocyte Fate
- Publication number 20140011281
- Publication date Jan 9, 2014
- DUKE UNIVERSITY
- Victor J. Dzau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of HASF as a Protective Agent Against Ischemic Tissue Damage
- Publication number 20120172306
- Publication date Jul 5, 2012
- Duke University
- Maria Mirotsou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Maria Mirotsou

Person

Patents Grantslast 30 patents

Direct reprogramming of cells to cardiac myocyte fate

Direct reprogramming of cells to cardiac myocyte fate

Inhibition of histone methyltransferase for cardiac reprogramming

Direct reprogramming of cells to cardiac myocyte fate

Method of reducing cell death by administering a paracrine factor d...

Method of reducing cell death by administering a nucleic acid encod...

Method of reducing cell death by administering a paracrine factor o...

Patents Applicationslast 30 patents

DIRECT REPROGRAMMING OF CELLS TO CARDIAC MYOCYTE FATE

INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING

Direct Reprogramming of Cells to Cardiac Myocyte Fate

STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS

Inhibition of Histone Methyltransferase for Cardiac Reprogramming

Stem Cell Derived Factors for Treating Pathologic Conditions

Stem Cell Derived Factors for Treating Pathologic Conditions

Direct Reprogramming of Cells to Cardiac Myocyte Fate

Use of HASF as a Protective Agent Against Ischemic Tissue Damage